Novel harmala-ocudelic tuning (HOT) for ocular disorders

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• The eye has serotonin receptors, and drugs affecting serotonin can impact vision.
• Harmine, a plant-derived indole alkaloid, is a potential candidate for vision improvement due to its interaction with serotonergic systems.
• Certain plants containing harmine are Generally Recognized as Safe (GRAS) and have traditional medicinal uses.

Purpose of the Study:

• To explore harmine and related compounds as potential therapeutic agents for vision enhancement.
• To investigate the mechanism of action involving serotonergic receptors in the eye.
• To assess the feasibility of using harmala alkaloid-containing plants for treating ocular disorders like presbyopia.

Main Methods:

• Review of existing knowledge on serotonin's role in ocular function and the effects of related drugs.
• Hypothesizing harmine's mechanism of action as a modulator of ocular serotonergic receptors.
• Proposing blinded research protocols involving harmala alkaloids, psychedelic therapy accoutrements, and assessment of visual acuity.

Main Results:

• Harmine may offer long-lasting vision benefits from single or few administrations.
• Potential for therapeutic effects on vision, possibly lasting months to years.
• The approach may be minimally hallucinogenic and well-tolerated at individualized doses.

Conclusions:

• Harmine-containing plants present a novel, potentially safe approach for vision improvement.
• Further research, including blinded clinical trials with specific therapeutic protocols, is warranted.
• Co-ingestion with dimethyltryptamine-containing plants might enhance retinal benefits.